ADVENZYMES — Advanced Enzyme Technologies Balance Sheet
0.000.00%
- IN₹35.04bn
 - IN₹29.96bn
 - IN₹6.37bn
 
- 95
 - 29
 - 57
 - 68
 
Annual balance sheet for Advanced Enzyme Technologies, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
R2021 March 31st  | 2022 March 31st  | 2023 March 31st  | 2024 March 31st  | 2025 March 31st  | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — | 
| Source: | ARS | ARS | ARS | ARS | ARS | 
| Standards: | IAS | IAS | IAS | IAS | IAS | 
| Status: | Final | Final | Final | Final | Final | 
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 3,225 | 3,781 | 4,848 | 5,480 | 5,951 | 
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 953 | 997 | 1,062 | 1,034 | 1,205 | 
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 5,160 | 6,044 | 7,221 | 8,097 | 8,799 | 
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 2,510 | 2,718 | 2,888 | 3,073 | 3,146 | 
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 11,562 | 12,676 | 14,218 | 15,355 | 16,213 | 
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 676 | 604 | 776 | 1,064 | 968 | 
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 1,852 | 1,703 | 1,752 | 1,991 | 1,882 | 
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 9,709 | 10,974 | 12,467 | 13,364 | 14,331 | 
| Total Liabilities & Shareholders' Equity | 11,562 | 12,676 | 14,218 | 15,355 | 16,213 | 
| Total Common Shares Outstanding |